Fig. 7From: Macrophage migration inhibitory factor contributes to the pathogenesis of benign lymphoepithelial lesion of the lacrimal glandMIF contributes to resistance to apoptosis in BLEL primary cells. (a) Immunoblotting showing the influence of MIF on Bax and Bcl-2 proteins expression. (b) Representative images of immunostaining showing the influence of MIF on Bcl-2 expression in BLEL primary cells. (c) Flow Cytometry graphs showing viable cells (lower-left quadrant), early apoptotic cells (lower- right quadrant), late apoptotic cells (upper-right quadrant) and nuclear debris (upper-left quadrant). (d) MIF prevents BLEL primary cells from DMSO-induced apoptosis. In (a & c) BLELp1 and BLELp2 cells were seeded at a density of 106 cells/dish, and at a density of 2 × 104 cells/well in 24 well plate in (b & d). Cells were treated with MIF (200 ng/ml), ISO-1 (100 μM) or without MIF nor ISO-1 for 72 h or 1 week in (a), and for 1 week in (b & c). In (d), cells were pre-treated with or without MIF (200 ng/ml) for 48 h before exposition to 1% DMSO (78.13 g/mol) for 24 h together with or without MIF (200 ng/ml). Data were plotted as Mean ± SEM. * P-value < 0.05; ** P-value < 0.01; *** P-value < 0.001; no stars for P-value > 0.05. Original magnification: (b) 20× and (d) 4×Back to article page